相似文献
1
What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Rigorous Simian Immunodeficiency Virus Vaccine Trials Can Be Instructive.
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):a029504. doi: 10.1101/cshperspect.a029504.
2
Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials.
Nat Rev Immunol. 2009 Oct;9(10):717-28. doi: 10.1038/nri2636.
3
Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01687-18. Print 2019 Feb 15.
4
Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00721-18. Print 2018 Oct 1.
5
Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
Antiviral Res. 1991 May;15(4):267-86. doi: 10.1016/0166-3542(91)90009-g.
6
Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.
J Virol. 2015 Aug;89(16):8130-51. doi: 10.1128/JVI.01221-14. Epub 2015 May 27.
7
Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges.
J Virol. 2018 May 14;92(11). doi: 10.1128/JVI.02198-17. Print 2018 Jun 1.
8
Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.
J Virol. 2004 Mar;78(5):2212-21. doi: 10.1128/jvi.78.5.2212-2221.2004.
9
Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
AIDS. 1998 Jan 1;12(1):1-10. doi: 10.1097/00002030-199801000-00001.
10
Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
J Infect Dis. 2004 Nov 1;190(9):1697-705. doi: 10.1086/424600. Epub 2004 Sep 24.
引用本文的文献
1
The heart of the matter: modeling HIV-associated cardiovascular comorbidities in nonhuman primate models.
Front Cell Infect Microbiol. 2025 Apr 22;15:1556315. doi: 10.3389/fcimb.2025.1556315. eCollection 2025.
2
Tetravalent SARS-CoV-2 S1 Subunit Protein Vaccination Elicits Robust Humoral and Cellular Immune Responses in SIV-Infected Rhesus Macaque Controllers.
bioRxiv. 2023 Mar 16:2023.03.15.532808. doi: 10.1101/2023.03.15.532808.
3
Morphine suppresses peripheral responses and transforms brain myeloid gene expression to favor neuropathogenesis in SIV infection.
Front Immunol. 2022 Nov 16;13:1012884. doi: 10.3389/fimmu.2022.1012884. eCollection 2022.
4
Antiretroviral therapy restores the homeostatic state of microglia in SIV-infected rhesus macaques.
J Leukoc Biol. 2022 Nov;112(5):969-981. doi: 10.1002/JLB.3HI0422-635R. Epub 2022 Jun 10.
5
Nonhuman Primates in Translational Research.
Annu Rev Anim Biosci. 2022 Feb 15;10:441-468. doi: 10.1146/annurev-animal-021419-083813.
6
Increased IL-6 expression precedes reliable viral detection in the rhesus macaque brain during acute SIV infection.
JCI Insight. 2021 Oct 22;6(20):e152013. doi: 10.1172/jci.insight.152013.
7
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.
PLoS Pathog. 2021 Jul 6;17(7):e1009278. doi: 10.1371/journal.ppat.1009278. eCollection 2021 Jul.
8
Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection against Simian Immunodeficiency Virus SIVmac239 Acquisition.
J Virol. 2021 Jun 24;95(14):e0033021. doi: 10.1128/JVI.00330-21.
9
Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.
J Virol. 2020 Nov 23;94(24). doi: 10.1128/JVI.00979-20.
10
Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics.
Eur J Pharm Sci. 2020 Aug 1;151:105387. doi: 10.1016/j.ejps.2020.105387. Epub 2020 May 23.
本文引用的文献
1
Rapid development of a DNA vaccine for Zika virus.
Science. 2016 Oct 14;354(6309):237-240. doi: 10.1126/science.aai9137. Epub 2016 Sep 22.
2
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.
Science. 2016 Sep 9;353(6304):1129-32. doi: 10.1126/science.aah6157. Epub 2016 Aug 4.
3
Vaccine protection against Zika virus from Brazil.
Nature. 2016 Aug 25;536(7617):474-8. doi: 10.1038/nature18952. Epub 2016 Jun 28.
4
A rhesus macaque model of Asian-lineage Zika virus infection.
Nat Commun. 2016 Jun 28;7:12204. doi: 10.1038/ncomms12204.
5
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition.
Nat Med. 2016 Jul;22(7):762-70. doi: 10.1038/nm.4105. Epub 2016 May 30.
6
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.
N Engl J Med. 2016 Jun 2;374(22):2120-30. doi: 10.1056/NEJMoa1508952. Epub 2016 May 18.
7
Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
Science. 2016 Feb 12;351(6274):714-20. doi: 10.1126/science.aac9475. Epub 2016 Jan 21.
8
Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.
Science. 2015 Jul 17;349(6245):320-4. doi: 10.1126/science.aab3886. Epub 2015 Jul 2.
9
Bottlenecks in HIV-1 transmission: insights from the study of founder viruses.
Nat Rev Microbiol. 2015 Jul;13(7):414-25. doi: 10.1038/nrmicro3471. Epub 2015 Jun 8.
10
The chimpanzee model for hepatitis B virus infection.
Cold Spring Harb Perspect Med. 2015 Jun 1;5(6):a021469. doi: 10.1101/cshperspect.a021469.
Zotero 插件